What should I disclose before testing?

Drug and alcohol testing programs commonly request disclosure of prescription medications, over-the-counter products, supplements, and certain medical treatments before testing because these substances may affect preliminary screening results or laboratory interpretation. Documented medication history can help laboratories and medical review officers evaluate whether a detected substance is consistent with legitimate medical use. Disclosure procedures vary depending on the testing program and the setting in which testing occurs.

Prescription medications involving opioids, amphetamines, benzodiazepines, stimulant medications, sleep aids, or other controlled substances are particularly relevant because they may appear on standard testing panels. Some over-the-counter products and supplements may also contribute to cross-reactivity during initial screening procedures. Providing accurate medication information may reduce confusion during confirmatory review.

Testing programs often distinguish between screening analysis and final result interpretation. Preliminary immunoassay screening identifies broad substance categories, while confirmation testing determines specific compounds and metabolite patterns more precisely. Medical review procedures may then compare laboratory findings with documented medication history before final reporting occurs.

Disclosure requirements may differ between workplace, legal, athletic, treatment, and healthcare settings. Some programs request medication information before sample collection, while others involve follow-up review only if screening results are positive. Privacy protections and reporting procedures also vary according to regulatory and organizational policies.

Laboratory interpretation typically considers medication disclosure alongside testing methodology, confirmation analysis, and metabolite concentration levels. Legitimate prescription use does not automatically prevent substances from appearing on a test, particularly when the prescribed medication itself is included within the screening panel. The evaluation process therefore often involves both analytical testing data and verified medical information.